clinical trial · NCT06225050
M-2018-334 in Hematological Malignancies
Miltenyi Biomedicine GmbH·N/A·not yet recruiting·n = 18
Hematological MalignanciesCliniMACS Prodigy® LP-TCRα/β-19-45RA (Trial Version)
brief summary
This is a single-center, open-label, single-arm, pilot clinical study using TCRα/β and CD45RA depleted stem cell grafts from haploidentical donors for hematopoietic cell transplantation in 12 to 18 adult patients.
started
Feb 28, 2026
primary completion
Feb 28, 2029
completion
Feb 28, 2029
last updated
Dec 3, 2025
official title
A Single-center Pilot Study Using TCRα/β and CD45RA Depleted Stem Cell Grafts From Haploidentical Donors for Hematopoietic Cell Transplantation in Adults(HAPLO2022)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol